Abstract
High-dose liquid antibiotics are uncommon in bone cement. We present a case series of patients in which up to 16 mL of liquid amikacin (250 mg mL - 1 ) was successfully incorporated into bone cement to treat periprosthetic joint infections. We did not observe adverse drug reactions definitively attributed to its use.
Original language | English (US) |
---|---|
Pages (from-to) | 147-150 |
Number of pages | 4 |
Journal | Journal of Bone and Joint Infection |
Volume | 6 |
Issue number | 5 |
DOIs | |
State | Published - 2021 |
Bibliographical note
Copyright: © 2021 Don Bambino Geno Tai et al.PubMed: MeSH publication types
- Journal Article